Evidence map›Paper›PMID 42666322›Full record

ArticleFrontiers in pediatrics2026

Association between cytokine levels and disease relapse in newly diagnosed childhood-onset primary nephrotic syndrome.

Chenxi Wei, Chang Zheng, Tingyu Shen, Lijun Jiang, Xingjie Qi, Zanhua Rong

Abstract read
In one paragraph

Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chenxi WeiDepartment of Pediatrics, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Chang ZhengDepartment of Pediatrics, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Tingyu ShenDepartment of Pediatrics, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Lijun JiangDepartment of Pediatrics, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Xingjie QiDepartment of Pediatrics, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Zanhua RongDepartment of Pediatrics, The Second Hospital of Hebei Medical University, Shijiazhuang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Although most pediatric patients with primary nephrotic syndrome (PNS) are steroid-sensitive, some develop steroid dependence and experience disease relapse. Therefore, identifying risk factors associated with PNS relapse is clinically important. Methods: This retrospective study included 74 children with newly diagnosed PNS and 39 healthy children as controls. Patients with PNS were classified into relapse and non-relapse groups according to whether relapse occurred within 6 months after disease onset. Serum cytokine levels and peripheral blood lymphocyte subsets were measured using enzyme-linked immunosorbent assays and flow cytometry, respectively. Results: Demographic characteristics and laboratory findings did not differ significantly between male and female children with PNS. Compared with healthy controls, patients with PNS exhibited abnormal white blood cell and platelet counts, an elevated erythrocyte sedimentation rate, and increased absolute counts of peripheral blood lymphocyte subsets (all Conclusions: IL-1β positivity is associated with relapse within 6 months of onset in children with newly diagnosed PNS. Further studies are required to validate this association and elucidate the underlying mechanisms.

Indexed as

cytokineinterleukin-1βpediatricperipheral lymphocyte subsetsprimary nephrotic syndrome

Identifiers

PMID42666322
PMCPMC13522141

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.